Results 141 to 150 of about 1,470 (198)

Development and External Validation of a Multivariable Model to Predict Early Minimal Symptom Expression Response in Adult Generalized Myasthenia Gravis Patients Treated With Efgartigimod. [PDF]

CNS Neurosci Ther
Yang Y, Liang T, Zhao M, Yang H, Zhao Z, Yu L, Yan L, Li S, Zhang P, Qi G, Yin J, Xu Z, Luo Z.   +12 more
europepmc   +1 more source

Case Report: Guillain-Barré syndrome temporally associated with levofloxacin exposure and improvement following efgartigimod treatment. [PDF]

Front Immunol
Xie S, Zhang Y, Shen F, Wu L, Tang Y, Li J.   +5 more
europepmc   +1 more source

Rapid Symptomatic Improvement and Long-Term Minimal Symptom Expression in a Myasthenia Gravis Patient Treated With Zilucoplan Without Maintenance Cholinesterase Inhibitors, Corticosteroids, or Immunosuppressants: A Case Report. [PDF]

Cureus
Amano R.
europepmc   +1 more source

Immunotherapy in Chronic Inflammatory Demyelinating Polyneuropathy and the Emerging Role of Efgartigimod. [PDF]

J Clin Neurol
Park JS, Kang M.
europepmc   +1 more source

Efgartigimod Combined with Glucocorticoids in the Treatment of Severe Generalized Myasthenia Gravis: A Single-Center, Retrospective Cohort Study. [PDF]

Neurol Ther
Gu S, Li Y, Dong H, Yang H, Ma M, Li M, Yan C, Jia P, Wang Y, Qi G.   +9 more
europepmc   +1 more source

Effective Subcutaneous Efgartigimod Treatment in a 90-Year-Old Female With Myasthenia Gravis. [PDF]

J Clin Neurol
Nosaki Y, Yokoi T, Iwai K.
europepmc   +1 more source

Advances in the treatment of autoimmune nodopathy: based on treatment strategies of CIDP. [PDF]

Front Immunol
Pang ZD, Sun H, Wei XJ, Nie CP, Yu XF.
europepmc   +1 more source

Pharmacovigilance analysis of FcRn antagonists in the treatment of myasthenia gravis: A disproportionality analysis based on the FAERS database. [PDF]

Hum Vaccin Immunother
Liu B, Zhang W, Chen Y, Han A, Chen D.
europepmc   +1 more source

The conserved human astrovirus-receptor interface reveals a targetable vulnerability for antiviral development. [PDF]

Nat Commun
Wang W, Xu Y, Li Z, Liu, Ma K, Wang R, Chen R, Shu B, Sun X, Liu Y, Ke X, Zhang S.   +11 more
europepmc   +1 more source